MoneyWorks4Me

USFDA completes inspection at Dr. Reddy's Srikakulum Plant

16 Jan 2019 Evaluate

Untited state Food and Drug Administration (USFDA) has completed audit of Dr. Reddy's Laboratories’ Formulations Srikakulum Plant (SEZ) Unit I in the state of Andhra Pradesh. The company has been issued a Form 483 with 4 observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..